<mods xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" ID="P0b002ee180371e87">
<name type="corporate">
 <namePart>United States Government Publishing Office</namePart>
 <role>
  <roleTerm authority="marcrelator" type="text">publisher</roleTerm>
  <roleTerm authority="marcrelator" type="code">pbl</roleTerm>
</role>
 <role>
  <roleTerm authority="marcrelator" type="text">distributor</roleTerm>
  <roleTerm authority="marcrelator" type="code">dst</roleTerm>
</role>
</name>
<name type="corporate">
 <namePart>United States</namePart>
 <namePart>Government Accountability Office</namePart>
 <role>
  <roleTerm authority="marcrelator" type="text">author</roleTerm>
  <roleTerm authority="marcrelator" type="code">aut</roleTerm>
</role>
 <description>Government Organization</description>
</name>
<typeOfResource>text</typeOfResource>
<genre authority="marcgt">government publication</genre>
<language>
 <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</language>
<extension>
 <collectionCode>GAOREPORTS</collectionCode>
 <category>Legislative Agency Publications</category>
 <waisDatabaseName>gao</waisDatabaseName>
 <branch>legislative</branch>
 <dateIngested>2010-08-12</dateIngested>
</extension>
<originInfo>
 <publisher>U.S. Government Printing Office</publisher>
 <dateIssued encoding="w3cdtf">2005-06-30</dateIssued>
 <issuance>monographic</issuance>
</originInfo>
<physicalDescription>
 <note type="source content type">deposited</note>
 <digitalOrigin>born digital</digitalOrigin>
 <extent>20 p.</extent>
</physicalDescription>
<classification authority="sudocs">GA 1.13:GAO-05-863T</classification>
<identifier type="uri">https://www.govinfo.gov/app/details/GAOREPORTS-GAO-05-863T</identifier>
<identifier type="local">P0b002ee180371e87</identifier>
<identifier type="former package identifier">f:d05863t</identifier>
<recordInfo>
 <recordContentSource authority="marcorg">DGPO</recordContentSource>
 <recordCreationDate encoding="w3cdtf">2010-08-12</recordCreationDate>
 <recordChangeDate encoding="w3cdtf">2011-03-24</recordChangeDate>
 <recordIdentifier source="DGPO">GAOREPORTS-GAO-05-863T</recordIdentifier>
 <recordOrigin>machine generated</recordOrigin>
 <languageOfCataloging>
  <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</languageOfCataloging>
</recordInfo>
<accessCondition type="GPO scope determination">fdlp</accessCondition>
<extension>
 <docClass>REPORT</docClass>
 <accessId>GAOREPORTS-GAO-05-863T</accessId>
 <reportNumber>GAO-05-863T</reportNumber>
 <subject>Disease detection or diagnosis</subject>
 <subject>Emergency preparedness</subject>
 <subject>Immunization programs</subject>
 <subject>Immunization services</subject>
 <subject>Infectious diseases</subject>
 <subject>Procurement planning</subject>
 <subject>Strategic planning</subject>
 <subject>Federal/state relations</subject>
 <subject>Health care planning</subject>
 <subject>State-administered programs</subject>
 <subject>Influenza</subject>
 <type>Testimony</type>
 <accountNo>A28577</accountNo>
</extension>
<titleInfo>
 <title>Influenza Pandemic: Challenges in Preparedness and Response</title>
</titleInfo>
<abstract>Shortages of influenza vaccine in the 2004-05 and previous
influenza seasons and mounting concern about recent avian	 
influenza activity in Asia have raised concern about the nation&apos;s
preparedness to deal with a worldwide influenza epidemic, or	 
influenza pandemic. Although the extent of such a pandemic cannot
be predicted, according to the Centers for Disease Control and	 
Prevention (CDC), an agency within the Department of Health and  
Human Services (HHS), it has been estimated that in the absence  
of any control measures such as vaccination or antiviral drugs, a
&quot;medium-level&quot; influenza pandemic could kill up to 207,000 people
in the United States, affect from 15 to 35 percent of the U.S.	 
population, and generate associated costs ranging from $71	 
billion to $167 billion in the United States. GAO was asked to	 
discuss the challenges the nation faces in responding to the	 
threat of an influenza pandemic, including the lessons learned	 
from previous annual influenza seasons that can be applied to its
preparedness and overall ability to respond to a pandemic. This  
testimony is based on GAO reports and testimony issued since 2000
on influenza vaccine supply, pandemic planning, emergency	 
preparedness, and emerging infectious diseases and on current	 
work examining the influenza vaccine shortage in the United	 
States for the 2004-05 influenza season.</abstract>
<location>
 <url displayLabel="HTML rendition" access="raw object">https://www.govinfo.gov/content/pkg/GAOREPORTS-GAO-05-863T/html/GAOREPORTS-GAO-05-863T.htm</url>
 <url displayLabel="PDF rendition" access="raw object">https://www.govinfo.gov/content/pkg/GAOREPORTS-GAO-05-863T/pdf/GAOREPORTS-GAO-05-863T.pdf</url>
</location>
<identifier type="preferred citation">GAO-05-863T</identifier>
<location>
 <url displayLabel="Content Detail" access="object in context">https://www.govinfo.gov/app/details/GAOREPORTS-GAO-05-863T</url>
</location>
<note>Testimony</note>
<extension>
 <searchTitle>GAO-05-863T; Influenza Pandemic: Challenges in Preparedness and Response;
            </searchTitle>
</extension>
<subject>
 <topic>Disease detection or diagnosis</topic>
 <topic>Emergency preparedness</topic>
 <topic>Immunization programs</topic>
 <topic>Immunization services</topic>
 <topic>Infectious diseases</topic>
 <topic>Procurement planning</topic>
 <topic>Strategic planning</topic>
 <topic>Federal/state relations</topic>
 <topic>Health care planning</topic>
 <topic>State-administered programs</topic>
 <topic>Influenza</topic>
</subject>
</mods>